Copyright
©The Author(s) 2016.
World J Transplant. Jun 24, 2016; 6(2): 255-271
Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.255
Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.255
Center, authors, year, ref., study design and follow-up | Number and type of transplant | Complications | Readmissions, reoperation, length of stay | 1 yr patient survival | 1 yr kidney and pancreas graft survival |
University of Tennessee, Stratta et al[122], Retrospective, mean follow-up 3 yr | PE 126; 90 SPK; 18 PAK; 18 PTA; Era 1 (10/90-6/95); Era 2 (7/95-5/98); Era 3 (6/98-12/99) | In 3 successive eras, rates of acute rejection were 63%, 33%, and 39%, respectively; rates of major infection were 60%, 43%, and 44%, respectively | In 3 successive eras, rates of relaparotomy were 47%, 31%, and 33%, respectively; rates of thrombosis were 20%, 7%, and 6%, respectively. Mean length of stay: 12.5 d | In 3 successive eras, patient survival was 77%, 93%, and 100%, respectively | In 3 successive eras, kidney graft survival was 77%, 93%, and 94%, respectively; pancreas graft survival was 60%, 83%, and 83%, respectively |
Università di Pisa, Italy, Boggi et al[17], Retrospective, mean follow-up 21 ± 20 mo | PE 110 | 10 grafts were lost; 3 acute rejection, 2 chronic rejection, 2 venous thrombosis, 2 deaths, 1 late thrombosis (6 mo). Incidence of pancreas acute rejection was 6% | Relaparotomy rate was 13.6%; Mean length of stay was 26 ± 14 d; One month readmission rate was 13% | 98% | Pancreas graft survival was 91% |
University of Chicago, Bruce et al[116], Retrospective, mean follow-up 16 mo | PE 70 | Pancreas graft losses: Thrombosis (3), acute rejection (5), late duodenal perforation (2) | Total 1st year hospitalization: 37 ± 28 d; Relaparotomy in 14 (70%) | 88% | Kidney 78%; Pancreas 79% |
Louisiana State University, Zibari et al[23], Retrospective, mean follow-up 25 mo | PE 21 | Postoperative Bleeding in 4, wound infections in 4, acute rejection in 9, pancreas graft loss in 2 | Mean length of stay was 16 d | 100% | Kidney 90%; Pancreas 90% |
Wake Forest Baptist Medical Center, Rogers et al[4], Retrospective, mean follow-up 6 ± 3 yr | 202; SPK 162, PAK 35, PTA 5; PE 179; SE 23 | Thrombosis rate was 8%; acute rejection rate was 28%; major infection rate was 50% | Mean length of stay was 13 d; Relaparotomy rate was 38% | Overall patient survival was 87%; one-year patient survival was 97% | Overall kidney and pancreas graft survival rates are 76% and 65%; death-censored graft survival rates are 84% and 72%, and one year graft survival rates are 94% and 88%, respectively |
Monash Medical Centre, Victoria, Australia, Kave et al[118], Retrospective, mean follow-up 2 yr | SB 37; PE 27 | Pancreas graft thrombosis rates SB 10.8%, PE 7.4% (P = NS) | Two-year patient survival was SB 94.3% vs PE 96.0% | Two year kidney (SB 89.2% vs PE 85.2%); pancreas (SB 77.9% vs PE 71.4%) |
- Citation: El-Hennawy H, Stratta RJ, Smith F. Exocrine drainage in vascularized pancreas transplantation in the new millennium. World J Transplant 2016; 6(2): 255-271
- URL: https://www.wjgnet.com/2220-3230/full/v6/i2/255.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i2.255